Breast Implant-Associated Anaplastic Large Cell Lymphoma

At The Institute for Advanced Reconstruction, we strive to provide all patients with the safest surgical treatment options. Staying up-to-date on the benefits and risks associated with the procedures that we offer is a top priority of our surgeons. We also ensure that our patients are properly educated on the risks and benefits of procedures, so they are able to make  informed decisions regarding their care.

The U.S. Food & Drug Administration has released a statement on Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL). Below is an excerpt from their statement, highlighting background information on BIA-ALCL and providing their recommendations for patients. The full article can be accessed on the FDA website.

If you have any additional questions or concerns regarding BIA-ALCL or breast reconstruction, please contact The Institute for Advanced Reconstruction at (844) 920-0212 to schedule an appointment with one of our plastic and reconstructive surgeons. Additional information regarding BIA-ALCL can be found at www.fda.gov.

Share With Friends